Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2022-02-24 2022-02-24
Drug Identification Number 02042274 02042274
Brand name INDERAL-LA INDERAL-LA
Common or Proper name INDERAL-LA INDERAL-LA
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE
Strength(s) 160MG 160MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100's 100's
ATC code C07AA C07AA
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-24 2022-02-24
Estimated end date Unknown Unknown
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments